A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy

Mixed dyslipidemia, characterized by a lipid triad of elevated triglycerides (TG), elevated low-density lipoprotein-cholesterol (LDL-C) and reduced high-density lipoprotein-cholesterol (HDL-C), is a common and frequently difficult to manage condition. The use of combination medications is often need...

Descripción completa

Detalles Bibliográficos
Autores principales: Strain, Joe D, Farver, Debra K, Clem, James R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262365/
https://www.ncbi.nlm.nih.gov/pubmed/22291492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262365/
https://www.ncbi.nlm.nih.gov/pubmed/22291492

Ejemplares similares